Status:
UNKNOWN
Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury
Lead Sponsor:
Henri Mondor University Hospital
Conditions:
Stroke
Walking, Difficulty
Eligibility:
All Genders
18+ years
Brief Summary
The retrospective study investigates the part of responsibility of neuromuscular disorders associated with chronic hemiparesis in walking impairment.
Detailed Description
After injury to the central nervous system, walking disorders are associated with complex neuromuscular mechanisms that alter the direction and intensity of the descending control, reflex reactions to...
Eligibility Criteria
Inclusion
- Adult
- Person who performed tridimensional gait analysis in laboratory
- Person who had a stroke at least 6 months before the gait analysis
Exclusion
- Any other neurological pathology or gait disorders
- Botulinum toxin injection in the last 3 months before the gait analysis
Key Trial Info
Start Date :
October 19 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06107556
Start Date
October 19 2023
End Date
June 30 2024
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire Analyse et Restauration du Mouvement
Créteil, France